
|Videos|February 16, 2023
Case 2: Faricimab in treatment naïve neovascular nAMD patient
Advertisement
Drs Khanani and Khoramnia review the case of a newly diagnosed nAMD patient who showed a rapid response in disease control after starting faricimab therapy.
Sponsored by Roche
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
How European clinicians are revolutionizing retina care
2
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
3
Clinical Insights Shaping Real-World Decision-Making in Geographic Atrophy
4
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
5









































